PCR / NGS
QUASAR-BRCA1/2
The testing kit is designed to detect germline and somatic mutations in the BRCA1, BRCA2 genes by NGS-sequencing and is recommended for determining predisposition to developing hereditary forms of breast cancer, ovarian cancer in healthy women, and when examining patients diagnosed with breast cancer and ovarian cancer in order to determination of effective treatment tactics.
Designed by